Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of authorisation: 22/12/2011, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Vyloy, Zolbetuximab, Date of authorisation: 19/09/2024, Status: Authorised

Human medicines European public assessment report (EPAR): Pemetrexed Accord, pemetrexed, Date of authorisation: 18/01/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Mektovi, binimetinib, Date of authorisation: 20/09/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 14, Status: Authorised

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2024

What we publish on medicines and when

CHMP PROM minutes for the meeting on 17 June 2024

Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 2, Status: Authorised